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ABSTRACT -Aminobutyric acid type A (GABAA) receptors are members of the ligand-gated ion channel gene superfamily.
Using the substituted cysteine accessibility method, we investigated whether residues in the 1M3 membrane-spanning
segment are water-accessible. Cysteine was substituted, one at a time, for each M3 residue from 1Ala
291 to 1Val
307. The
ability of these mutants to react with the water-soluble, sulfhydryl-specific reagent pCMBS was assayed electrophysiologi-
cally. Cysteines substituted for 1Ala
291 and 1Tyr
294 reacted with pCMBS applied both in the presence and in the absence
of GABA. Cysteines substituted for 1Phe
298, 1Ala
300, 1Leu
301, and 1Glu
303 only reacted with pCMBS applied in the
presence of GABA. We infer that the pCMBS reactive residues are on the water-accessible surface of the protein and that
GABA induces a conformational change that increases the water accessibility of the four M3 residues, possibly by inducing
the formation of water-filled crevices that extend into the interior of the protein. Others have shown that mutations of 1Ala
291,
a water-accessible residue, alter volatile anesthetic and ethanol potentiation of GABA-induced currents. Water-filled crevices
penetrating into the interior of the membrane-spanning domain may allow anesthetics and alcohol to reach their binding sites
and thus may have implications for the mechanisms of action of these agents.
INTRODUCTION
The binding of GABA to the GABAA receptors stimulates
the opening and subsequent desensitization of an anion-
selective channel that is an integral part of the receptor
(Amin and Weiss, 1993; Macdonald and Olsen, 1994; Ma-
conochie et al., 1994; Rabow et al., 1995; Jones et al.,
1998). The nature of the conformational changes that un-
derlie these functional state changes is unknown. Numerous
GABAA receptor subunits have been cloned (Wisden and
Seeburg, 1992; Macdonald and Olsen, 1994; Rabow et al.,
1995). The subunits are members of the neurotransmitter-
gated ion channel gene superfamily that includes receptors
for glycine, acetylcholine (ACh), and serotonin (Macdonald
and Olsen, 1994; Jackson and Yakel, 1995; Karlin and
Akabas, 1995; Rabow et al., 1995). Each subunit has a
similar transmembrane topology, with a 200 amino acid
extracellular N-terminal domain, four membrane-spanning
segments (M1, M2, M3, and M4), a large intracellular loop
between M3 and M4, and a short extracellular C-terminus
(Schofield et al., 1987; Macdonald and Olsen, 1994). The
GABAA receptor subunit stoichiometry varies in different
brain regions, but a common subunit stoichiometry is 2 , 2
, and 1  subunits (Backus et al., 1993; Chang et al., 1996;
McKernan and Whiting, 1996; Tretter et al., 1997; Farrar et
al., 1999). The five subunits are arranged pseudosymmetri-
cally around a central pore (Nayeem et al., 1994). Thus each
subunit contributes to the channel lining. Using the substi-
tuted cysteine accessibility method (SCAM) (Akabas et al.,
1992, 1994; Xu and Akabas, 1993), we previously identi-
fied nine putative, channel-lining residues in the 1M2
membrane-spanning segment (Xu and Akabas, 1993, 1996).
Based on the pattern formed by these residues, we proposed
that the M2 segment secondary structure was largely -he-
lical. Furthermore, we inferred that the gate, the charge-
selectivity filter, and the picrotoxin binding site were lo-
cated near the cytoplasmic end of the channel (Xu et al.,
1995; Xu and Akabas, 1996).
Little is known about the role of the M3 membrane-
spanning segment in the structure and function of the
GABAA receptor. Residues aligned with 1Ala
291, near the
extracellular end of M3, were implicated in the ability of
volatile anesthetics and alcohols to potentiate GABA-in-
duced currents (Mihic et al., 1997; Krasowski et al.,
1998a,b; Wick et al., 1998). In the homologous ACh recep-
tor mutations of M3 residues altered gating kinetics (Cam-
pos-Caro et al., 1997; Wang et al., 1999). The secondary
structure of the ACh receptor M3 segment was inferred to
be largely -helical (Blanton and Cohen, 1994; Gorne-
Tschelnokow et al., 1994; Corbin et al., 1998; Lugovskoy et
al., 1998; Methot and Baenziger, 1998), although others
inferred that M3 was not helical (Unwin, 1993).
We have used the substituted cysteine accessibility
method to identify residues in the M3 membrane-spanning
segment that are on the water-accessible surface of the
GABAA receptor. Cysteines substituted for six M3 residues
reacted with charged, hydrophilic, sulfhydryl-specific re-
agents in a GABA-dependent manner. We propose that
conformational changes occurring during gating induce the
formation of water-filled crevices that extend into the inte-
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rior of the membrane-spanning domain of the protein. The
mechanism of action of general anesthetics and alcohols
that potentiate GABA-induced currents may involve inter-
actions with residues lining these water-filled crevices.
MATERIALS AND METHODS
Substituted cysteine accessibility method
SCAM provides a systematic approach to the identification of residues on
the water-accessible surface of a protein. In this method individual residues
in largely hydrophobic membrane-spanning segments are mutated, one at
a time, to cysteine. The cysteine substitution mutants are expressed heter-
ologously. If the functional properties of the mutant channels are similar to
wild type, we assay the ability of charged, sulfhydryl-specific reagents to
react with the engineered cysteines. In the GABAA receptor we assay
modification electrophysiologically by a change in the peak current in-
duced by test pulses of GABA applied before and after application of the
sulfhydryl reagent. If the peak current after application of the sulfhydryl
reagent is significantly different from the initial peak current, we infer that
the reagent reacted with the engineered cysteine.
The reagents that we used include the mercurial derivative p-chloro-
mercuribenzenesulfonate (pCMBS) and the methanethiosulfonate (MTS)
derivatives MTS-ethylammonium (MTSEA) and MTS-ethyltrimethylam-
monium (MTSET). pCMBS reacts with cysteine to covalently add
HgC6H4SO3
 to the sulfhydryl. The MTS derivatives add -SCH2CH2X to
the cysteine, where X is NH3
 for MTSEA and N(CH3)3
 for MTSET.
pCMBS reacts 103 times faster with ionized thiolates (-S) than with
un-ionized thiols (-SH), and the MTS reagents react 5  109 times faster
with ionized thiolates than with thiols (Hasinoff et al., 1971; Roberts et al.,
1986). We assume that only cysteines on the water-accessible surface of a
protein ionize to any significant extent; thus we infer that reactive cysteines
are on the water-accessible surface of the protein. In addition, pCMBS
and MTSET are membrane impermeant (VanSteveninck et al., 1965;
Holmgren et al., 1996; Olami et al., 1997), and thus when they are applied
extracellularly they only have access to residues that are on the extracel-
lular, water-accessible surface of the protein.
In solution pCMBS becomes p-hydroxy-mercuribenzenesulfonate
(Boyer, 1954). Although we were unable to find a measurement of the
ionization constant for the hydroxyl from p-hydroxy-mercuribenzenesul-
fonate, the ionization constant for phenylmercuric hydroxide was reported
to be 1 1010 (Waugh et al., 1955); similar values have been reported for
other organic mercurials (Waugh et al., 1955; Simpson, 1961). Assuming
this ionization constant, at our bath pH, 7.5, less than 0.03% of the
p-hydroxy-mercuribenzenesulfonate would be ionized and therefore zwit-
terionic. Thus we assume that pCMBS is negatively charged in solution
at pH 7.5.
Mutagenesis and expression
Residues 1Ala
291 to 1Val
307 in the rat GABAA 1 subunit were mutated,
one at a time, to cysteine, using the Altered Sites method (Promega,
Madison, WI) (except for F304C, which was done by polymerase chain
reaction). The mutants were subcloned into the 1pGEMHE vector (Ho-
renstein and Akabas, 1998) and confirmed by DNA sequencing. mRNA
was synthesized from the 1, 1, and 2 pGEMHE plasmids with T7 RNA
polymerase and injected into Xenopus oocytes at a ratio of 1 1:1 1:1 2
(200 pg/nl) in 50 nl of diethylpyrocarbonate-treated water as described (Xu
and Akabas, 1993).
Electrophysiology
GABA-induced currents were recorded from individual oocytes 1–5 days
after mRNA injection, using a two-electrode voltage-clamp setup. Elec-
trodes were filled with 3 M KCl and had a resistance of 2 M. The
ground electrode was connected to the bath with a 3 M KCl/agar bridge.
Data were acquired and analyzed on a 486/33 MHz PC computer with a
TEV-200 amplifier (Dagan, Minneapolis MN), a TL-1 DMA data interface
(Axon Instruments, Foster City, CA), and programs written in Axobasic
(Axon Instruments). The oocyte was continuously perfused at 5 ml/min
with calcium-free frog Ringer’s (CFFR) (115 mM NaCl, 2.5 mM KCl, 1.8
mM MgCl2, 10 mM HEPES, pH 7.5) at room temperature. All solutions
were made and diluted in CFFR. The holding potential was 80 mV.
Experimental protocol
Effects of sulfhydryl reagents on GABA-induced currents were assayed
using the following sequence of reagents: 100 M GABA, 20 s; 100 M
GABA, 20 s; EC50 GABA, 20 s; EC50 GABA, 20 s; sulfhydryl reagent 
100 M GABA, 1 min; 100 M GABA, 20 s; 100 M GABA, 20 s; EC50
GABA, 20 s; EC50 GABA, 20 s (see Fig. 1 for examples). The applications
of GABA and reagents were separated by 3- to 5-min washes with CFFR
to allow recovery from desensitization. The fractional effect of the sulf-
hydryl reagent was taken as {IGABA, after/IGABA, before)  1} * 100, where
IGABA, after is the average peak current of the two GABA test pulses after
the application of the sulfhydryl reagent and IGABA, before is the average of
the peak current of the initial two GABA applications. Test pulses of
GABA were applied at two concentrations, EC50 and more than five times
EC50, i.e., near saturating GABA. Changes in the peak current induced by
the EC50 GABA test pulses are more sensitive to effects of modification on
gating kinetics, whereas changes in the peak current induced by the
saturating GABA test pulses are more sensitive to effects of modification
on conductance (Zhang and Karlin, 1998). The following concentrations of
sulfhydryl reagents were used: 0.5 mM pCMBS, 2.5 mM MTSEA, and
1 mM MTSET. pCMBS was obtained from Sigma (St. Louis, MO),
MTS reagents were obtained from Toronto Research Chemicals (North
York, ON, Canada).
For pCMBS, the primary reagent that we used to screen GABAA
receptor cysteine-substitution mutants, we applied the reagent for 1 min at
0.5 mM. This combination of time and concentration was chosen because
they were the maximum concentration and duration that caused no signif-
icant increase in the leak conductance of uninjected Xenopus oocytes. This
limits our ability to detect reactive residues. As discussed below, for a
given mutant, given the variability of responses, application of a reagent
must cause a net change in current greater than 30% to be significantly
different statistically from wild type by a one-way analysis of variance (for
n between 4 and 6). Given this threshold and the reaction conditions that
we used for pCMBS (0.5 mM applied for 1 min), if complete reaction
caused 100% inhibition of the GABA-induced current, we would detect as
reactive positions with a second-order reaction rate greater than 12 l/mol-s.
Measurement of reaction rates
We measured the rates of reaction of pCMBS with the engineered
cysteines by determining the effect of sequential brief applications of
pCMBS. A test pulse of GABA was applied, and the GABA-induced
current was measured. GABA plus a lower concentration of pCMBS (0.1
or 0.2 mM) was applied for 15–20 s. After washout of pCMBS, a test
pulse of GABA was applied, and the GABA-induced current was mea-
sured. The effect of four or five brief, sequential applications of pCMBS
was determined. The magnitudes of the GABA test currents were normal-
ized relative to the initial test pulse. The normalized current was plotted as
a function of the cumulative duration of pCMBS treatment and fitted with
a single exponential decay function, using Prism2 software (GraphPad, San
Diego, CA). The pseudo-first-order rate constant obtained from the expo-
nential fit was divided by the pCMBS concentration to yield the second-
order rate constant.
Curve fitting and statistics
Data are expressed as the percentage change in current after modification
for the appropriate concentration of GABA. The significance of the dif-
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ference between each mutant and wild type was determined by one-way
ANOVA, using the Student-Newman-Kuels post hoc test (SPSS for Win-
dows; SPSS, Chicago, IL). Dose-response curves were fit using Prism
software (GraphPad). A paired t-test was used to determine the significance
of differences in GABA EC50 before and after treatment with pCMBS
.
It is important to recognize that we assay reactive residues based on the
functional effect of modification. We identify functional effects based on
the statistical significance of the effect on a mutant relative to the effect on
wild type. For mutants where the average effect after application of
pCMBS is small, whether the effect is judged to be significant depends,
in part, on the stringency of the one-way ANOVA post hoc test used. For
example, if we were to use the less stringent Duncan post hoc test, then an
additional residue F296C would be judged to be reactive with pCMBS in
the presence of GABA (Fig. 2 B). The choice of post hoc test is, unfortu-
nately, somewhat arbitrary.
RESULTS
Expression of the cysteine mutants
We substituted cysteines, one at a time, for 17 consecutive
residues, from 1Ala
291 to 1Val
307, in the M3 membrane-
spanning segment of the rat 1 subunit. The mutant 1
subunits were expressed with wild-type 1 and 2 subunits
in Xenopus oocytes. One to two days after mRNA injection
GABA-induced currents were observed for all of the mu-
tants. For oocytes expressing wild type the average peak
current induced by 100 M GABA (V 	 80 mV) was
1.9  0.5 A, and for the mutants it ranged between 0.2 
0.1 A for A300C and 3.7  0.2 A for A305C (Table 1).
We measured the EC50 for GABA activation of wild-type
receptor and each of the cysteine substitution mutants. For
wild-type receptor the GABA EC50 was 2.1 1.3 M (n	
6), and for the mutants the GABA EC50 ranged between
0.5  0.1 M for A291C and Y294C and 48  15 M for
L301C (Table 1). Thus all of the mutants assembled and
displayed GABA-induced currents similar to wild type.
Therefore, we assumed that the structures of the mutants
were similar to the structure of wild type. Cysteine substi-
tutions in the ACh receptor M1 and M2 segments caused
a similar range of changes in the ACh EC50 (Akabas et al.,
1994; Akabas and Karlin, 1995). We infer that the changes
in EC50 were due to changes in the gating kinetics and not
to structural perturbations of the distant ligand-binding site.
Reactions with pCMBS applied in the absence
of GABA
In the absence of GABA the channels are largely in the
closed state. We showed previously that when assayed with
near-saturating GABA test pulses a 1-min application of 0.5
mM pCMBS had no effect on the subsequent GABA-
induced currents in wild-type receptors (Xu and Akabas,
1996). For wild type we have now obtained the same result
when EC50 GABA test pulses were used (Fig. 2 A). We infer
FIGURE 1 Effect of 0.5 mM pC-
MBS on GABA-induced currents
from individual oocyte expressing
several M3 segment cysteine-substi-
tution mutants. (A) pCMBS applied
in the absence of GABA inhibits sub-
sequent EC50 GABA-induced cur-
rents in an oocyte expressing
1A291C. (B) pCMBS
 applied in
the presence of GABA inhibits subse-
quent GABA-induced currents in an
oocyte expressing 1A291C. (C)
pCMBS potentiates subsequent
EC50 GABA-induced currents for the
mutant 1F298C. (D) pCMBS
 ap-
plied in the presence of GABA inhib-
its subsequent GABA-induced cur-
rents in an oocyte expressing
1E303C. For all records, holding po-
tential is 80 mV. Bars above traces
indicate the period of application of
reagents.
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that the endogenous cysteine residues were inaccessible for
reaction with pCMBS, or reaction with pCMBS had no
functional effects.
When assayed using EC50 GABA test pulses, a 1-min
application of 0.5 mM pCMBS applied in the absence of
GABA irreversibly inhibited the subsequent GABA-in-
duced currents for the A291C mutant (Figs. 1 A and 2 A, top
bar in each pair of bars). When assayed with near-saturat-
ing GABA test pulses, the subsequent GABA-induced cur-
rents of both A291C and Y294C were inhibited (Fig. 2 A).
In the absence of GABA the receptor was in the closed state,
although brief spontaneous openings may have occurred.
The rate of spontaneous openings in 112 GABAA recep-
tors has not been measured; however, in the ACh receptor
spontaneous openings occur with a probability of less than
1 in 105 (Jackson, 1984). Thus we feel that reactions of
pCMBS applied in the absence of GABA with A291C and
Y294C were occurring in the closed state and not during
brief spontaneous openings.
Reactions with pCMBS applied in the presence
of GABA
In the presence of GABA the receptor undergoes transitions
mainly between the open and desensitized states. We
showed previously that when assayed with near-saturating
GABA test pulses a 1-min application of 0.5 mM pCMBS
FIGURE 2 The irreversible effect
of a 1-min application of 0.5 mM
pCMBS, applied in the absence (A)
or in the presence (B) of 100 M
GABA on subsequent GABA-in-
duced currents of wild-type and mu-
tant GABAA receptors. For each mu-
tant the results are shown for test
pulses at the GABA EC50 (top bar,
gray) and at a saturating concentra-
tion of GABA (lower bar, white).
Solid bars indicate effects that are
significantly different statistically
from the effect on wild type by a
one-way ANOVA, using the Student-
Newman-Kuels post hoc test. A neg-
ative effect indicates inhibition of
subsequent GABA-induced currents;
a positive effect indicates potentia-
tion of subsequent GABA-induced
currents. The means and SEMs are
shown. For each condition the results
of 3–20 oocytes are averaged.
TABLE 1 GABA EC50 and maximum currents for the M3
cysteine substitution mutants
Mutant n EC50 (M) Imax (nA) Hill coeff.
A291C 3 0.5  0.1 2420  422 1.13  0.40
V292C 3 4.9  1.6 1516  105 0.82  0.12
WT, C293* 6 2.1 1.3 1877  467 1.29  0.19
Y294C 3 0.5  0.1 970  235 1.72  0.56
A295C 3 2.8  0.7 1729  410 0.59  0.06
F296C 4 1.4  0.4 1482  78 0.80  0.02
V297C 3 2.4  0.6 2274  63 1.00  0.08
F298C 4 28.4  4.0 1876  526 1.06  0.30
S299C 3 4.5  0.2 1884  439 0.91  0.18
A300C 4 3.5  0.5 224  53 0.66  0.01
L301C 4 48.0  15.0 907  225 1.01  0.03
I302C 3 1.9  0.8 921  165 0.96  0.18
E303C 4 1.4  0.3 1033  273 0.93  0.11
F304C 3 1.7  0.3 1564  283 1.01  0.12
A305C 3 1.2  0.3 3743  202 1.14  0.21
T306C 4 0.9  0.3 1076  145 1.28  0.24
V307C 4 9.0  3.8 910  234 0.82  0.18
*Note that the results for wild type (WT) are given at the position of the
endogenous M3 segment cysteine, 1Cys
293.
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applied in the presence of 100 M GABA had no effect on
the subsequent GABA-induced currents of wild type (Xu
and Akabas, 1996). For wild type we have now obtained the
same result when EC50 GABA test pulses were used (Fig. 2
B). We infer that in the presence of GABA the endogenous
cysteine residues were inaccessible for reaction with
pCMBS or reaction with pCMBS had no functional
effects.
For the cysteine-substitution mutants, a 1-min application
of 0.5 mM pCMBS  100 M GABA irreversibly altered
the subsequent GABA-induced currents of the mutants
A291C and Y294C, which also reacted with pCMBS
applied in the absence of GABA. In addition, when
pCMBS was applied in the presence of GABA the currents
for the mutants F298C, A300C, L301C, and E303C were
also irreversibly altered (Figs. 1 and 2 B). For the mutants
A291C, Y294C, and E303C pCMBSmodification resulted
in inhibition of the subsequent currents induced by near-
saturating concentrations of GABA. The E303C mutant also
showed inhibition of currents induced by test pulses of
GABA at the EC50 concentration (Fig. 2 B).
For the other mutants, F298C, A300C, and L301C,
pCMBS modification potentiated the subsequent GABA-
induced currents. For F298C and L301C the potentiation
was observed for currents induced by EC50 GABA concen-
trations. This potentiation was due to a decrease in the
GABA EC50 after covalent modification. For the F298C
mutant the GABA EC50 was 28  4 M before modifica-
tion by pCMBS and decreased to 15  2 M (n 	 4; p 	
0.03) after modification by pCMBS (Fig. 3). Similarly, for
the L301C mutant, the GABA EC50 was 48  15 M
before modification by pCMBS and decreased to 24  8
M (n 	 4; p 	 0.05) after modification by pCMBS. For
both mutants pCMBS modification did not alter the max-
imum current induced by saturating concentrations of
GABA. Similar covalent modification induced changes in
EC50 were seen for some cysteine substitution mutants in
the M2 segment of the ACh receptor  and  subunits
(Akabas et al., 1994; Zhang and Karlin, 1998). Because
these residues are far from the agonist binding site, we
assume that these changes in EC50 arose because of changes
in gating kinetics and not because of changes in the affinity
of the binding site for agonist (Akabas et al., 1994;
Colquhoun, 1998). In the case of the A300C mutant, the
post-pCMBS test current induced by a near-saturating
concentration of GABA was potentiated, but the post-pC-
MBS test current induced by the EC50 GABA concentra-
tion was not altered (Fig. 2 A). For A300C, pCMBS
modification did not alter the GABA EC50 (data not shown).
The increase in current for A300C may result from an
increase in single-channel conductance.
We attempted to measure the voltage dependence of the
rates of reaction of pCMBS with E303C, the most cyto-
plasmic of the accessible residues. The second-order reac-
tion rate constant for pCMBS with E303C in the presence
of GABA at a holding potential of 80 mV was 273  62
l/mol-s (n 	 3). This rate was about 5- to 10-fold slower
than the rates of reaction of pCMBS with M2 segment
residues (Horenstein and Akabas, unpublished results). The
reaction rate with E303C was similar at 80 and 10 mV.
Thus there was no evidence that the reaction rate of
pCMBS with E303C was voltage dependent.
In the presence of GABA the receptor undergoes transi-
tions between the open and desensitized states. The reaction
with pCMBS appeared to occur in a nonconducting state
of the channel because for the F298C, A300C, L301C, and
E303C mutants the current during a 1-min application of 0.5
mM pCMBS  100 MGABA could be superimposed on
the current induced by a 1-min application of 100 M
GABA alone (Fig. 4); however, after the reagents were
washed out, subsequent applications of GABA test pulses
showed that the peak currents were markedly altered after
pCMBS  GABA but not after GABA alone. If reaction
were occurring in the open state we would have expected
the time dependence of the current during the application of
pCMBS  GABA to be different from the current ob-
served with GABA alone. Alternatively (but, we feel, less
likely), modification in the open state may not affect con-
ductance but may affect subsequent reopening from the
closed state. Therefore, we infer that in the presence of
GABA pCMBS reacted during a nonconducting, desensi-
tized state, a state that does not readily return to the open
state during continuous application of GABA.
There are several potential interpretations for those cys-
teine substitution mutants where the effect of application of
the sulfhydryl reagent was not significantly different from
that of wild type. Some or all of these residues may be
inaccessible to pCMBS, and thus there was no reaction at
these positions. Similarly, they may have been accessible,
but the rate of reaction of pCMBS may have been lower
than our detection threshold. Alternatively, reaction may
have occurred at some or all of these positions, but covalent
FIGURE 3 pCMBS modification reduces the GABA EC50 of the
F298C mutant. Results are shown for an individual oocyte. The GABA
dose-response curve was determined (E). 0.5 mM pCMBS  100 M
GABA was applied for 1 min, and then the GABA dose-response curve
was determined again (F). The data were fit with a sigmoid dose-response
curve shown by the solid line. For this oocyte the EC50 was 29 M before
pCMBS and 15 M afterward. Similar results were obtained in three
other oocytes.
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modification may have no functional effect on the subse-
quent GABA-induced currents. We cannot distinguish be-
tween these possibilities, and thus the negatives must be
interpreted with caution. Finally, we do not believe that the
negatives result from a failure of the 1 subunit cysteine
substitution mutants to express because expression of only
the 1 and 2 subunits gives currents that are less than 20
nA (Sigel et al., 1990) (data not shown), and all of the
cysteine substitution negatives had peak GABA-induced
currents greater than 750 nA (Table 1).
Reactions with cationic MTS reagents
A 1-min application of 2.5 mM MTSEA in the absence of
GABA had no effect on wild type or on any of the cysteine-
substitution mutants (Fig. 5 A).
FIGURE 4 pCMBS appears to react with 1E303C
in a desensitized state of the receptor. (A) Currents
recorded from a single oocyte during 1-min applica-
tions of 100 M GABA in the absence (first and third
traces) and in the presence (second trace) of 0.5 mM
pCMBS. Note that currents of the first and second
traces are very similar (these traces are superimposed in
B). This indicates that pCMBS does not significantly
alter the current during application of pCMBS, but the
subsequent GABA-induced currents (third trace) are
markedly reduced. (B) The first two traces in A are
superimposed. Thin line, Trace of GABA alone; thick
line, pCMBS  GABA. Bars above traces indicate
the period of application of reagents. Holding potential,
80 mV.
FIGURE 5 The irreversible effect
of a 1-min application of 2.5 mM
MTSEA, applied in the absence (A)
or in the presence (B) of 100 M
GABA, on subsequent GABA-in-
duced currents of wild-type and mu-
tant GABAA receptors. For each mu-
tant the results are shown for test
pulses at the GABA EC50 (top bar,
gray) and at a saturating concentra-
tion of GABA (lower bar, white).
Solid bars indicate effects that are
significantly different statistically
from the effect on wild type by a
one-way ANOVA, using the Student-
Newman-Kuels post hoc test. A neg-
ative effect indicates inhibition of
subsequent GABA-induced currents;
a positive effect indicates potentia-
tion of subsequent GABA-induced
currents. The means and SEMs are
shown. For each condition the results
of three to eight oocytes are
averaged.
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A 1-min application of 2.5 mM MTSEA  100 M
GABA irreversibly inhibited the subsequent GABA-in-
duced current of the mutant Y294C but had no effect on
subsequent GABA-induced currents for the other cysteine
substitution mutants (Fig. 5). For those mutants that reacted
with pCMBS  GABA we assayed to see if MTSEA
was reacting but having no effect on GABA-induced cur-
rents. If MTSEA were reacting it would prevent a subse-
quent application of pCMBS  GABA from having an
effect. For the mutants A300C and E303C preapplication of
MTSEA prevented pCMBS from reacting subsequently
(Fig. 6 B). Similar effects were observed with a 1-min
application of 1 mM MTSET, which is permanently pos-
itively charged (data not shown). Thus we inferred that the
cationic MTS reagents reacted with Y294C, A300C, and
E303C. MTSEA and MTSET did not react with the other
M3 segment pCMBS reactive residues. For example, as
shown in Fig. 6 A, preapplication of MTSEA did not
prevent subsequent reaction by pCMBS with 1F298C.
Accessibility of the M2 segment residue 1Ser
270
Mutations of 1Ser
270 and/or the aligned residues in the 
subunits alter the ability of loreclezole and general anes-
thetics to potentiate GABA-induced currents (Wingrove et
al., 1994; Belelli et al., 1997; Mihic et al., 1997). We had
previously investigated the accessibility of 1S270C to co-
valent modification by pCMBS. We showed that when a
near-saturating concentration of GABA was used for the
test responses, pCMBS had no effect on the post-
pCMBS GABA-induced currents (Xu and Akabas, 1996).
We reinvestigated the accessibility of 1S270C, using
GABA test concentrations at the GABA EC50, which are
more sensitive to modifications that effect only gating ki-
netics (Zhang and Karlin, 1998) because modification that
alters gating kinetics but not conductance may not alter
currents induced by near-saturating GABA concentrations.
When the reactivity of 1S270C12 was tested using EC50
GABA concentrations, a 1-min application of 0.5 mM
pCMBS applied in the absence of GABA inhibited sub-
sequent GABA-induced currents by 43  9% (n 	 3). A
1-min application of 0.5 mM pCMBS in the presence of
100 M GABA inhibited the subsequent GABA-induced
currents by 46  4% (n 	 5) (Fig. 7). Thus we infer that
cysteine substituted for 1Ser
270 reacted with pCMBS
both in the presence and in the absence of GABA.
DISCUSSION
We have shown that pCMBS added extracellularly reacted
with cysteines substituted for six of 17 M3 membrane-
spanning segment residues and with the M2 residue
1S270C. We infer that these sulfhydryl-reactive residues
were exposed, at least transiently, on the water-accessible
surface of the protein for several reasons. First, the sulfhy-
dryl reagents react faster with the ionized thiolate form of
cysteine (-S) than with the uncharged thiol form (-SH);
pCMBS reacts 103 times faster and the MTS reagents react
5  109 times faster (Hasinoff et al., 1971; Roberts et al.,
1986). Only cysteines on the water-accessible surface will
ionize to a significant extent. Second, at pH 7.5, pCMBS
and MTSET are permanently charged and membrane im-
permeant (VanSteveninck et al., 1965; Holmgren et al.,
1996; Olami et al., 1997). Therefore, they are unlikely to
enter hydrophobic regions in the lipid bilayer or in the
interior of proteins. This implies that these reagents traverse
FIGURE 6 Effect of pretreatment with 2.5 mM MTSEA on the sub-
sequent response to 0.5 mM pCMBS application in the pCMBS reactive
mutants. (A) For the F298C mutant, application of MTSEA has little
effect, but subsequent application of pCMBS causes marked potentiation.
This indicates that the MTSEA had not reacted with this mutant. (B) For
the E303C mutant, application of MTSEA has no effect on the subse-
quent current; however, the subsequent application of 0.5 mM pCMBS
also has no effect. This indicates that the MTSEA must have reacted with
the cysteine, thereby preventing reaction with pCMBS, which would have
inhibited this mutant. Bars above traces indicate the period of application
of reagents. Holding potential, 80 mV.
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an aqueous pathway to the reactive cysteines. Third, Falke
and colleagues showed that cysteine reactivity was well
correlated with solvent accessibility measured from the x-
ray crystal structure in the extracellular domain of the
aspartate chemotaxis receptor (Danielson et al., 1997). Thus
we infer that the substituted cysteines and their correspond-
ing wild-type residues, 1Ala
291, 1Tyr
294, 1Phe
298,
1Ala
300, 1Leu
301, 1Glu
303, and 1Ser
270 are exposed, at
least transiently, on the water-accessible surface.
The reactivity of four of the six M3 segment residues was
dependent on the functional state of the receptor. The two
most extracellular reactive residues, A291C and Y294C,
and the M2 residue S270C reacted both in the presence and
in the absence of GABA. These were accessible both in the
closed and in an activated state. In contrast, the reactions
with the four residues closer to the cytoplasmic end of M3,
F298C, A300C, L301C, and E303C, were state dependent.
These four mutants only reacted with pCMBS applied in
the presence of GABA. In the presence of GABA the
channels fluctuate mainly between the open and desensi-
tized states. Our observation that the GABA-induced cur-
rent during the 1-min application of pCMBS could be
superimposed on the current induced by GABA in the
absence of pCMBS, yet the subsequent GABA-induced
currents following pCMBS were irreversibly altered (Fig.
4) suggests that reaction occurred in a desensitized state.
Alternatively, reaction might have occurred in the open state
if it did not alter conduction but rather the kinetics of
subsequent reopening of the channels. This, we think, is
unlikely because even during a 1-min application of GABA
the channels pass through the closed state, and this would
result in an alteration of the current profile in the presence
of pCMBS. We conclude that pCMBS most likely re-
acted with the four residues, F298C, A300C, L301C, and
E303C, in a nonconducting state, a state from which chan-
nels rarely return to the open state in the continued presence
of GABA, i.e., a desensitized state.
Our discovery that M3 segment residues are on the water-
accessible surface of the protein is surprising. There was no
previous evidence that M3 might form part of the channel
lining or that water-filled crevices might extend into the
interior of the protein. Thus a critical issue raised by our
findings is the water-accessible surface with which these
residues are in contact—the water-filled ion channel or a
water-filled crevice that extends, perhaps transiently, into
the interior of the membrane-spanning domain of the pro-
tein. The secondary structure of the M2 segment appears to
be -helical, and residues on one side of the helix line the
channel (Xu and Akabas, 1996). The channel-lining resi-
dues in the GABA M2 segment, however, did not change
markedly in the presence and absence of GABA (Xu and
Akabas, 1996). Thus we think that it is unlikely that a major
conformational change occurs in the structure of the channel
lining, such as the M3 membrane-spanning segment moving
into the channel lining in the presence of GABA, although
we cannot exclude this possibility. Furthermore, in the ACh
receptor the channel is largely lined by residues from the
M2 segments (reviewed in Karlin and Akabas, 1995; Lester,
1995; Changeux and Edelstein, 1998). In the 9-Å resolution
structure of the ACh receptor channel the M2 segments
were closest to the central channel axis at the cytoplasmic
end and angled away from the channel axis toward the
extracellular end (Unwin, 1993). Thus other membrane-
spanning segments must fill the gaps between the M2 seg-
ments near the extracellular end, although they were not
seen in the 9-Å electron density map (Unwin, 1993). There
were water-accessible residues near the extracellular end of
the ACh receptor M1 segment, and we suggested that
these M1 residues might fill the spaces between the extra-
cellular ends of the M2 segment (Akabas and Karlin, 1995).
Residues from the M3 segment may also fill those gaps, but
a conformational change would be required to increase the
accessibility of the residues in the middle of the M3 seg-
ment, and as we noted above GABA did not induce major
changes in the M2 segment residues that line the channel
(Xu and Akabas, 1996). Another possibility is that the M3
segment faces the nonchannel lining side of the M2 seg-
ment, and in the absence of GABA a water-filled crevice
extends between the M2 and M3 segments from the extra-
cellular surface to the level of 1Tyr
294. The conformational
changes that follow GABA binding result in the crevice
extending deeper into the interior of the membrane-span-
ning domain, thereby increasing the accessibility of the
other M3 residues. There are several precedents for the
existence of water-filled crevices extending into the interior
of membrane-spanning domains of proteins. For example,
in G-protein-coupled receptors the ligand-binding site is
formed by residues in the membrane-spanning segments,
and access to the binding site is via a water-filled crevice
(Javitch et al., 1994, 1995a,b; Fu et al., 1996). In voltage-
dependent Na and K channels, it appears that two water-
filled crevices, one extending from the extracellular surface
FIGURE 7 pCMBS (0.5 mM) applied in the presence of GABA inhib-
its subsequent GABA-induced currents in an oocyte expressing the M2
segment 1S270C mutant when assayed with EC50 GABA test pulses. Bars
above traces indicate the period of application of reagents. Holding poten-
tial, 80 mV.
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and one from the cytoplasmic surface, contact the S4 volt-
age-sensing, membrane-spanning segment (Yang et al.,
1996; Baker et al., 1998; Cha and Bezanilla, 1998). Fur-
thermore, water-filled crevices and cavities have been iden-
tified in the interior of water-soluble proteins (Englander
and Kallenbach, 1983; Yu et al., 1999). Thus we conclude
that the sulfhydryl reactive M3 residues probably do not line
the ion channel. Rather, we speculate that a water-filled
crevice is present in the closed state. It is lined in part by the
M3 segment residues 1Ala
291, 1Tyr
294, and the M2 seg-
ment residue 1Ser
270. We do not know whether this crevice
is continuously present or arises because of fluctuations in
the protein structure. In the presence of GABA the crevice
extends deeper into the membrane-spanning domain,
thereby exposing 1Phe
298 and 1Leu
301. Whether the wa-
ter-filled crevice extends around the side of the helix to
expose 1Ala
300 and 1Glu
303 or a second water-filled
crevice extends from the surface to these residues is uncertain.
The lack of voltage dependence in the reaction of
pCMBS with E303C is consistent with reaction occurring
in a nonconducting state where the potential falls across the
gate rather than along the length of the channel or with the
residue being in a dead-end crevice where the electrical
potential does not fall in the crevice; these two possibilities
are not mutually exclusive. In the ACh receptor the reaction
rates of charged, sulfhydryl reagents with M2 segment
channel-lining, substituted cysteines were voltage depen-
dent in the open state but were not voltage dependent in the
closed state (Pascual and Karlin, 1998). There are also other
possible explanations for the lack of voltage dependence,
but our results do not allow us to distinguish among the
possibilities.
In contrast to our results in the M2 segment (Xu and
Akabas, 1996), the pattern formed by the M3 water-acces-
sible residues do not provide a clear indication of the M3
segment secondary structure. Furthermore, we do not know
whether they are accessible in the same state of the receptor.
The homologous ACh receptor evidence, including the pat-
tern of labeling by hydrophobic compounds and spectro-
scopic studies of peptides and fragments of ACh receptor
membrane-spanning domains, suggests that the M3 segment
secondary structure is largely -helical (Blanton and Cohen,
1994; Gorne-Tschelnokow et al., 1994; Methot et al., 1994;
Baenziger and Methot, 1995; Blanton et al., 1998; Lugov-
skoy et al., 1998). Unwin, however, inferred that only M2
was -helical, based on an electron density map (Unwin,
1993). Our results are inconsistent with a -strand second-
ary structure for the M3 segment.
We conducted a BLAST search, using the sequence in
and flanking the rat GABAA 1 M3 segment, that identified
179 sequences from GABAA, glycine, and GABAC receptor
subunits and invertebrate glutamate-gated chloride channels
(data not shown) (Altschul et al., 1990). Comparison of the
aligned sequences showed that the 1 subunit amino acid
was conserved in less than 60% of the sequences at the
positions aligned with 1Ala
291, 1Val
292, 1Ala
295,
1Ile
302, 1Ser
299, and 1Thr
306. When plotted on an -he-
lical wheel these positions lie on one face of the helix (Fig.
8). At one other position 1Tyr
294 tyrosine was conserved in
less than 60% of the sequences; however, as we showed,
this residue is on the water-accessible surface in both the
absence and presence of GABA. The other M3 residues are
conserved in more than 75% of the sequences, although, at
the positions aligned with 1Phe
298 and 1Phe
304, aromatic
FIGURE 8 -Helical representa-
tions of the residues in the rat 1 M3
membrane-spanning segment show-
ing the pCMBS reactive residues.
The pCMBS reactive residues are
indicated by solid triangles: upright
triangles if modification caused po-
tentiation of subsequent GABA-in-
duced currents and downward trian-
gles if modification caused inhibition
of subsequent GABA-induced cur-
rents. (A) -Helical net projection.
The x axis represents the circumfer-
ence of the helix. The y axis repre-
sents the distance along the helix; ex-
tracellular is at the top, intracellular at
the bottom. (B) -Helical wheel pro-
jection. In both A and B the residue
names in black boxes indicate posi-
tions where the 1 amino acid was
conserved at the aligned position in
less than 60% of 179 homologous
sequences identified in a BLAST
search. At the other positions the 1
subunit amino acid was conserved
in more than 75% of the aligned
positions.
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residues are conserved in more than 98% of the sequences,
but a specific aromatic residue is not. Sequence variability
is a common feature of solvent-exposed residues and of
residues exposed to the lipid bilayer, where the substitutions
are confined to hydrophobic amino acids (Baldwin, 1993;
Donnelly et al., 1993). We hypothesize that the variable side
of the M3 helix faces the lipid bilayer because the amino
acid substitutions are almost entirely hydrophobic and the
only polar substitutions are serine or threonine, which, in
-helices in hydrophobic environments, can satisfy their
side-chain hydrogen bonding requirements through interac-
tions with backbone carbonyls (Gray and Matthews, 1984).
The exception is 1Ala
291, which flanks the variable face of
the helix at the extracellular end of M3 and is on the
water-accessible surface of the protein. Aside from
1Ala
291, all of the water-accessible residues lie on the
conserved face of the helix (Fig. 8). In the ACh receptor,
one side of the M3 segment appears to face the lipid bilayer
(Blanton and Cohen, 1994; Blanton et al., 1998; Methot and
Baenziger, 1998); however, the position of the other side
relative to the channel and the interior of the protein is
unknown.
It is important to note that one of the original assumptions
of SCAM was that the only water-accessible residues in
membrane-spanning segments would be channel-lining res-
idues (Akabas et al., 1992; Xu and Akabas, 1993); this
appears to be incorrect. It is likely that the M2 segment
residues (Xu and Akabas, 1996) line the channel because
the rates of reaction of MTSES with the most cytoplasmic
M2 residue, 1V257C, were voltage dependent (Horenstein
and Akabas, unpublished results). Our current results raise
the possibility that water-filled crevices may extend into the
interior of other integral membrane proteins with important
functional consequences. The water-filled crevice that we
have inferred to be present in the GABAA receptor may
have a role in the molecular basis for the activity of several
general anesthetics, barbiturates, antiepileptic drugs
(loreclezole), alcohol, and neurosteroids. These drugs and
hormones potentiate GABA-induced currents. Mutations of
residues in various subunits aligned with 1Ser
270 in M2
and 1Ala
291 in M3 alter the effects of these compounds
(Wingrove et al., 1994; Koltchine et al., 1996; Belelli et al.,
1997; Mihic et al., 1997; Wick et al., 1998; Amin, 1999).
1Ser
270 is located on the opposite side of the M2 segment
helix from the channel-lining side, and we inferred that it
faced into the interior of the protein (Xu and Akabas, 1996).
We have now shown that 1Ser
270 and 1Ala
291 are both on
the water-accessible surface. These two residues may face
each other across a water-filled crevice, although this re-
mains to be determined. Perhaps the drugs intercalate into
the water-filled crevice and stabilize the open state of the
receptor. Consistent with this hypothesis, single-channel
kinetic analysis indicates that barbiturates increase the mean
open time, which is consistent with stabilization of an open
state (Study and Barker, 1981; MacDonald et al., 1989).
Further studies are in progress to investigate the effects of
these cysteine substitutions on the action of general anes-
thetics and other GABA modulatory drugs and to determine
whether activation of GABAA receptors by anesthetics and
barbiturates induces changes in accessibility of these M3-
substituted cysteines that are similar to the changes induced
by GABA.
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